Zhang M, Zhu Z, Zhang Y, Hu X
AIDS Res Ther. 2025; 22(1):16.
PMID: 39930454
PMC: 11812207.
DOI: 10.1186/s12981-025-00699-8.
Fei M, Zhang Y, Li H, Xu Q, Gao Y, Yang C
Int J Biol Sci. 2025; 21(2):614-631.
PMID: 39781455
PMC: 11705634.
DOI: 10.7150/ijbs.103032.
Al Sharie A, Al Masoud E, Jadallah R, Alzghoul S, Darweesh R, Al-Bataineh R
Medicine (Baltimore). 2024; 103(39):e39678.
PMID: 39331921
PMC: 11441924.
DOI: 10.1097/MD.0000000000039678.
Shen Y, Wang Z, Liu Z
Medicine (Baltimore). 2024; 103(37):e39631.
PMID: 39287262
PMC: 11404963.
DOI: 10.1097/MD.0000000000039631.
Rose T, Kim W
JAMA. 2024; 332(12):1001-1010.
PMID: 39196544
PMC: 11790279.
DOI: 10.1001/jama.2024.12848.
Early recurrence and extensive retroperitoneal metastasis after surgery for high‑grade mucinous tubular and spindle cell carcinoma: A case report and literature review.
Ma X, Xu J, Ye X, Yang F, Wang Z, Feng J
Oncol Lett. 2024; 28(4):467.
PMID: 39119228
PMC: 11306991.
DOI: 10.3892/ol.2024.14600.
Four years of natural progressive course: A rare case report of juvenile Xp11.2 translocations renal cell carcinoma with gene fusion.
Hu L, Li L, Li A, Tong J
Open Med (Wars). 2024; 19(1):20240985.
PMID: 38953008
PMC: 11215303.
DOI: 10.1515/med-2024-0985.
SETD7 Promotes Cell Proliferation and Migration via Methylation-mediated TAF7 in Clear Cell Renal Cell Carcinoma.
Zhang J, Duan B, Li F, Jing X, Li R, Cai S
Int J Biol Sci. 2024; 20(8):3008-3027.
PMID: 38904013
PMC: 11186372.
DOI: 10.7150/ijbs.93201.
Unconventional mechanism of action and resistance to rapalogs in renal cancer.
Yang J, Butti R, Cohn S, Toffessi-Tcheuyap V, Mal A, Nguyen M
Proc Natl Acad Sci U S A. 2024; 121(25):e2310793121.
PMID: 38861592
PMC: 11194491.
DOI: 10.1073/pnas.2310793121.
Using imaging to diagnose renal tumors beyond nephroblastoma.
Rhalem I, Bouanani Z, Akammar A, El Bouardi N, Alami B, Lamrani M
Radiol Case Rep. 2024; 19(7):2773-2780.
PMID: 38680746
PMC: 11046045.
DOI: 10.1016/j.radcr.2024.03.081.
Diagnostic magnetic resonance imaging characteristics of congenital mesoblastic nephroma: a retrospective multi-center International Society of Pediatric Oncology-Renal Tumor Study Group (SIOP-RTSG) radiology panel study.
van der Beek J, Schenk J, Morosi C, Watson T, Coma A, Graf N
Pediatr Radiol. 2024; 54(6):965-976.
PMID: 38609702
PMC: 11111520.
DOI: 10.1007/s00247-024-05918-4.
Solitary Clear Cell Renal Cell Carcinoma Metastasis to the Eyelid: A Case Report.
Zrinscak O, Kasumovic A, Krolo I, Ivekovic R, Malenica Ravlic M, Tomaskovic I
Case Rep Oncol. 2024; 17(1):477-483.
PMID: 38505734
PMC: 10950357.
DOI: 10.1159/000537860.
Elevated Plasma Concentration of 4-Pyridone-3-carboxamide-1-β-D-ribonucleoside (4PYR) Highlights Malignancy of Renal Cell Carcinoma.
Jedrzejewska A, Jablonska P, Gawlik-Jakubczak T, Czajkowski M, Maszka P, Mierzejewska P
Int J Mol Sci. 2024; 25(4).
PMID: 38397036
PMC: 10888534.
DOI: 10.3390/ijms25042359.
Synthesis and Biological Evaluation of β-Lactam Derivatives Targeting Speckle-Type POZ Protein (SPOP).
Zhou C, Hao X, Chen Z, Zhang R, Zhou Q, Fan Z
ACS Med Chem Lett. 2024; 15(2):270-279.
PMID: 38352842
PMC: 10860195.
DOI: 10.1021/acsmedchemlett.3c00515.
Therapeutic strategies and predictive models for Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma in adults based on data of two Chinese medical centers.
Yang Y, Zhao C, Wang Z, Liu F, Zhao M, Yang H
Aging (Albany NY). 2024; 16(2):1696-1711.
PMID: 38261736
PMC: 10866448.
DOI: 10.18632/aging.205452.
Assessment of the progression of kidney renal clear cell carcinoma using transcriptional profiles revealed new cancer subtypes with variable prognosis.
Livesey M, Eshibona N, Bendou H
Front Genet. 2023; 14:1291043.
PMID: 38075696
PMC: 10704507.
DOI: 10.3389/fgene.2023.1291043.
Renal cell carcinoma associated with Xp11.2 translocation/transcription factor E3 gene fusion: A case report and literature review.
Yang D, Tang W, Liu M, Xie Z, Shi F, Zhao Z
Oncol Lett. 2023; 27(1):29.
PMID: 38073770
PMC: 10698840.
DOI: 10.3892/ol.2023.14162.
Renal cell carcinoma in the contralateral kidney with TFE3 gene translocation following chemotherapy for childhood nephroblastoma: A case report and literature review.
Fujisawa S, Furukawa J, Hara T, Okada K, Chiba K, Nakano Y
Clin Case Rep. 2023; 11(11):e8128.
PMID: 37953896
PMC: 10632554.
DOI: 10.1002/ccr3.8128.
Establishment and validation of a nomogram to select patients with metastatic sarcomatoid renal cell carcinoma suitable for cytoreductive radical nephrectomy.
Zhou Y, Gu Y, Tang C, Dong J, Xu S, Sheng Z
Front Oncol. 2023; 13:1239405.
PMID: 37941564
PMC: 10627788.
DOI: 10.3389/fonc.2023.1239405.
A safe and effective treatment combination of neoadjuvant therapy and surgical resection for metastatic -rearranged renal cell carcinoma:a case report.
Yang H, Dong X, Pan X, Ma W, Pan J, Guo H
Front Oncol. 2023; 13:1252282.
PMID: 37936602
PMC: 10627181.
DOI: 10.3389/fonc.2023.1252282.